Literature DB >> 11395233

Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer.

G Adell1, H Zhang, A Jansson, X F Sun, O Stål, B Nordenskjöld.   

Abstract

BACKGROUND: Rectal cancer is a common malignancy, with significant local recurrence and death rates. Preoperative radiotherapy and refined surgical technique can improve local control rates and disease-free survival.
PURPOSE: To investigate the relationship between the tumor growth fraction in rectal cancer measured with Ki-67 and the outcome, with and without short-term preoperative radiotherapy.
METHOD: Ki-67 (MIB-1) immunohistochemistry was used to measure tumor cell proliferation in the preoperative biopsy and the surgical specimen. MATERIALS: Specimens from 152 patients from the Southeast Swedish Health Care region were included in the Swedish rectal cancer trial 1987-1990.
RESULTS: Tumors with low proliferation treated with preoperative radiotherapy had a significantly reduced recurrence rate. The influence on death from rectal cancer was shown only in the univariate analysis. Preoperative radiotherapy of tumors with high proliferation did not significantly improve local control and disease-free survival. The interaction between Ki-67 status and the benefit of radiotherapy was significant for the reduced recurrence rate (p = 0.03), with a trend toward improved disease-free survival (p = 0.08). In the surgery-alone group, Ki-67 staining did not significantly correlate with local recurrence or survival rates.
CONCLUSION: Many Ki-67 stained tumor cells in the preoperative biopsy predicts an increased treatment failure rate after preoperative radiotherapy of rectal cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395233     DOI: 10.1016/s0360-3016(01)01515-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  pRb2/p130 protein in relation to clinicopathological and biological variables in rectal cancers with a clinical trial of preoperative radiotherapy.

Authors:  Satish Babu Moparthi; Viveka Bergman; Gunnar Adell; Sten Thorstensson; Xiao-Feng Sun
Journal:  Int J Colorectal Dis       Date:  2009-07-14       Impact factor: 2.571

2.  Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer.

Authors:  Ivan Shabo; Hans Olsson; Rihab Elkarim; Xiao-Feng Sun; Joar Svanvik
Journal:  Cancer Microenviron       Date:  2014-04-28

3.  Predictive value of Smac, VEGF and Ki-67 in rectal cancer treated with neoadjuvant therapy.

Authors:  Hongjiang Yan; Renben Wang; Jinming Yu; Shumei Jiang; Kunli Zhu; Dianbin Mu; Zhongfa Xu
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

4.  Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.

Authors:  Robson Ferrigno; Paulo Eduardo Ribeiro dos Santos Novaes; Maria Letícia Gobo Silva; Ines Nobuko Nishimoto; Wilson Toshihiko Nakagawa; Benedito Mauro Rossi; Fábio de Oliveira Ferreira; Ademar Lopes
Journal:  Radiat Oncol       Date:  2006-03-28       Impact factor: 3.481

5.  Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma.

Authors:  A Toma; E Otsuji; Y Kuriu; K Okamoto; D Ichikawa; A Hagiwara; H Ito; T Nishimura; H Yamagishi
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

6.  Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients.

Authors:  Na Liu; Thomas R Cox; Weiyingqi Cui; Gunnar Adell; Birgitta Holmlund; Jie Ping; Ingvar Jarlsfelt; Janine T Erler; Xiao-Feng Sun
Journal:  Oncotarget       Date:  2016-05-26

7.  Livin expression is an independent factor in rectal cancer patients with or without preoperative radiotherapy.

Authors:  Zhen-Yu Ding; Hong Zhang; Gunnar Adell; Birgit Olsson; Xiao-Feng Sun
Journal:  Radiat Oncol       Date:  2013-12-02       Impact factor: 3.481

8.  AEG-1 expression is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy: a study in a Swedish clinical trial.

Authors:  S Gnosa; H Zhang; V P Brodin; J Carstensen; G Adell; X-F Sun
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.